GO:0106363 protein-cysteine methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106363 protein-cysteine methyltransferase activity catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a cysteine residue in a protein, producing S-adenosyl-L-homocysteine and S-methyl-L-cysteinyl-[protein].
• This activity is best known for its role in DNA repair, particularly in the direct reversal of O6-methylguanine lesions by O6-alkylguanine-DNA alkyltransferase (AGT), where the methyl group is transferred to a cysteine residue in the protein itself.
• The reaction is a suicide mechanism: the methylated protein is inactivated and often targeted for degradation, as shown for human MGMT.
• Protein-cysteine methyltransferase activity is conserved from bacteria to humans, with examples in Escherichia coli, Drosophila, and mammals.
• Deficiency in this activity leads to increased sensitivity to alkylating agents and is associated with cancer predisposition and resistance to chemotherapy.
• Studying this activity involves biochemical assays, structural biology, and CRISPR-based models to dissect its role in DNA repair and beyond.
Description
Protein-cysteine methyltransferase activity (GO:0106363) is a molecular function that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to a cysteine residue within a protein substrate, yielding S-adenosyl-L-homocysteine (SAH) and an S-methyl-L-cysteinyl-[protein]. This modification is unusual because it targets a cysteine thiol, forming a methylated cysteine that can alter protein function or stability. The best-characterized example is O6-alkylguanine-DNA alkyltransferase (AGT), also known as O6-methylguanine-DNA methyltransferase (MGMT), which repairs alkylated DNA by accepting the alkyl group onto its own cysteine residue, thereby restoring the DNA. This self-methylation is a stoichiometric, suicide reaction that inactivates the protein and triggers its degradation. Beyond DNA repair, protein-cysteine methyltransferase activity has been implicated in redox regulation and chromatin remodeling in plants. Understanding this activity is crucial for cancer research, as MGMT expression levels determine tumor sensitivity to alkylating chemotherapies. Moreover, the enzymatic mechanism provides a paradigm for direct protein methylation, a post-translational modification with emerging roles in signaling and epigenetics.
protein-cysteine methyltransferase activity At A Glance
| GO ID | GO:0106363 |
|---|---|
| GO term | protein-cysteine methyltransferase activity |
| Ontology | molecular_function |
| Synonym | protein cysteine methylase activity; protein cysteine methyltransferase activity |
| Major function | Catalyzes methyl transfer from S-adenosyl-L-methionine to a protein cysteine residue, forming S-methyl-L-cysteinyl-[protein] and S-adenosyl-L-homocysteine. |
| Reaction | L-cysteinyl-[protein] + S-adenosyl-L-methionine = H+ + S-adenosyl-L-homocysteine + S-methyl-L-cysteinyl-[protein] |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor |
| Substrate | Protein containing a target cysteine residue |
| Product | S-methyl-L-cysteinyl-[protein] and S-adenosyl-L-homocysteine |
What Is GO:0106363?
According to the Gene Ontology, GO:0106363 protein-cysteine methyltransferase activity is defined as the catalysis of the reaction: L-cysteinyl-[protein] + S-adenosyl-L-methionine = H+ + S-adenosyl-L-homocysteine + S-methyl-L-cysteinyl-[protein]. In simpler terms, it is an enzyme activity that transfers a methyl group from SAM to a cysteine residue on a protein, modifying that protein and releasing SAH. This activity is synonymous with protein cysteine methylase activity and protein cysteine methyltransferase activity.
Why Is protein-cysteine methyltransferase activity Important in Cell Biology?
Protein-cysteine methyltransferase activity is critically important because it mediates direct DNA repair and protein methylation, influencing genome stability, cancer development, and cellular responses to alkylating agents. The activity is essential for repairing O6-methylguanine adducts, which are cytotoxic and mutagenic if left unrepaired. Loss of this activity leads to increased mutation rates and sensitivity to alkylating chemotherapy, while overexpression confers resistance. Beyond DNA repair, cysteine methylation may regulate protein function and stability, as phosphorylation of methylated-DNA-protein-cysteine S-methyltransferase at serine-204 increases its resistance to proteolytic digestion. Thus, this activity is a key node in DNA damage response, cancer biology, and potentially other processes such as redox signaling.
• Direct reversal of O6-methylguanine DNA lesions, preventing mutations and cell death.
• Determines tumor sensitivity to alkylating chemotherapeutic agents such as temozolomide.
• Suicide inactivation and degradation of MGMT regulate DNA repair capacity.
• Conserved from bacteria to humans, with homologs in E. coli, Drosophila, and mammals.
• Involved in redox-dependent chromatin remodeling in plants, linking methylation to stress responses.
• Potential role in protein stability and post-translational regulation via cysteine methylation.
• Deficiency in repair-deficient cells leads to hypersensitivity to alkylating agents.
• Target for inhibitor development (e.g., O6-benzylguanine) to sensitize tumors to chemotherapy.
• Provides a model for studying enzyme-mediated methyl transfer to cysteine residues.
• Relevant to gastric cancer eradication strategies through understanding DNA repair.
Mechanism, Genes and Research Methods of protein-cysteine methyltransferase activity
Substrate Recognition and Binding
In simple terms: The enzyme first finds and binds to its target protein that has a specific cysteine residue.
The enzyme recognizes a substrate protein containing a reactive cysteine residue. In the case of O6-alkylguanine-DNA alkyltransferase (AGT), the target cysteine is located within a conserved active site motif (PCHR) that positions the cysteine for nucleophilic attack. Binding involves electrostatic and hydrophobic interactions that orient the cysteine thiol toward the methyl donor. Structural studies of human MGMT have revealed a helix-turn-helix domain that binds DNA and flips the damaged base into the active site, ensuring specificity for O6-methylguanine.
Methyl Transfer from S-adenosyl-L-methionine
In simple terms: The enzyme takes a methyl group from SAM and attaches it to the cysteine on the target protein.
Once the substrate is bound, the enzyme catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to the cysteine thiol, forming S-methyl-L-cysteinyl-[protein] and S-adenosyl-L-homocysteine (SAH). This reaction is a direct SN2-type displacement where the cysteine thiolate acts as a nucleophile, attacking the methyl group of SAM. The reaction is stoichiometric and irreversible, leading to inactivation of the enzyme.
Suicide Inactivation and Protein Degradation
In simple terms: After donating the methyl group, the enzyme is inactivated and often destroyed by the cell.
The methylated enzyme is no longer active and is rapidly degraded via the ubiquitin-proteasome pathway. Phosphorylation of methylated-DNA-protein-cysteine S-methyltransferase at serine-204 significantly increases its resistance to proteolytic digestion, suggesting a regulatory mechanism to control protein stability. This suicide mechanism ensures that each enzyme molecule can repair only one lesion, making the repair capacity dependent on new protein synthesis.
DNA Repair and Genome Maintenance
In simple terms: This activity fixes damaged DNA by removing harmful methyl groups, keeping the genome safe.
In DNA repair, AGT removes alkyl groups from O6-alkylguanine in DNA by transferring the alkyl group to its own cysteine residue, restoring guanine to its normal form. This prevents mutations and cytotoxicity caused by alkylating agents. Repair-deficient cells lacking this activity are hypersensitive to alkylating agents, as shown in human lymphoid cells. The activity is conserved in Drosophila and Escherichia coli, highlighting its fundamental role in genome maintenance.
Redox Regulation and Chromatin Remodeling
In simple terms: In plants, this activity may help control how DNA is packaged by responding to redox signals.
In plants, nitric oxide (NO) can modulate chromatin structure through redox-dependent mechanisms, potentially involving protein-cysteine methylation. S-nitroso-proteome analysis in poplar leaves under ozone stress identified proteins involved in redox regulation, suggesting crosstalk between cysteine methylation and redox signaling. These findings expand the role of protein-cysteine methyltransferase activity beyond DNA repair to include epigenetic and stress responses.
Key Genes Involved in GO:0106363 protein-cysteine methyltransferase activity
The following genes and proteins are directly associated with protein-cysteine methyltransferase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MGMT (human) | O6-methylguanine-DNA methyltransferase; repairs O6-alkylguanine lesions by accepting methyl groups onto Cys145 | Determines sensitivity to alkylating chemotherapy; prognostic marker in glioblastoma and other cancers |
| AGT (E. coli) | O6-alkylguanine-DNA alkyltransferase; direct repair of alkylated DNA | Model for studying suicide repair mechanisms and enzyme kinetics |
| Drosophila AGT | Methyltransferase activity involved in repair of alkylated DNA | Genetic model for DNA repair studies |
| Human MGMT variant (S204) | Phosphorylation at Ser204 increases resistance to proteolytic digestion | Regulation of protein stability and repair capacity |
| O6-benzylguanine target | Inhibitor of AGT; inactivates repair activity | Chemosensitization strategy in cancer therapy |
| Repair-deficient human lymphoid cells | Lack MGMT activity; hypersensitive to alkylating agents | Cell model for studying DNA repair deficiency |
| Plant redox-related proteins | Potential cysteine methylation in response to NO and ozone | Plant stress and chromatin remodeling research |
| SAM-dependent methyltransferases | General family of enzymes using SAM as methyl donor | Comparative enzymology and inhibitor design |
| Cysteine proteases | Contain reactive cysteines that could be methylated | Off-target effects and substrate specificity studies |
| Thioredoxin | Redox protein with cysteines; potential methylation target | Redox regulation and signaling |
| Histone proteins | Chromatin components with cysteines; potential methylation sites | Epigenetics and chromatin remodeling |
| p53 | Tumor suppressor with cysteines; potential methylation target | Cancer biology and DNA damage response |
| Ras GTPase | Signaling protein with cysteines; potential methylation target | Oncogenic signaling and redox regulation |
| Caspases | Apoptotic proteases with catalytic cysteines | Cell death and inflammation research |
| NF-kB | Transcription factor with redox-sensitive cysteines | Inflammation and immune response |
| Keap1 | Redox sensor with cysteines; potential methylation target | Oxidative stress response |
| PTEN | Tumor suppressor with cysteines; potential methylation target | Cancer and metabolism |
| SOD1 | Superoxide dismutase with cysteines; potential methylation target | Neurodegeneration and oxidative stress |
How Is protein-cysteine methyltransferase activity Regulated?
Protein-cysteine methyltransferase activity is regulated at multiple levels. The enzyme MGMT is transcriptionally regulated by promoter methylation, and its activity is consumed stoichiometrically during repair, requiring de novo synthesis for sustained repair. Phosphorylation at serine-204 increases resistance to proteolytic digestion, thereby modulating protein stability. Inhibitors such as O6-benzylguanine can inactivate the enzyme, leading to chemosensitization. In plants, redox signals such as nitric oxide may regulate chromatin remodeling through cysteine methylation. Additionally, the availability of SAM as a methyl donor can influence activity, linking cellular metabolism to methylation capacity.
protein-cysteine methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MGMT | Glioblastoma, chemoresistance | Knockout glioma cell lines; point mutation at Cys145 |
| MGMT | Gastric cancer | Patient-derived organoids; CRISPR knockout |
| AGT (E. coli) | DNA repair deficiency | Bacterial knockout strains; complementation assays |
| Drosophila AGT | Alkylation sensitivity | Drosophila knockout; survival assays |
| Human lymphoid cells | Repair deficiency | CRISPR knockout in lymphoblastoid cell lines |
Cancer and Chemoresistance
MGMT (O6-methylguanine-DNA methyltransferase) activity is a major determinant of tumor response to alkylating agents like temozolomide. High MGMT expression leads to chemoresistance, while low expression increases sensitivity. In gastric cancer, eradication strategies may benefit from understanding DNA repair pathways. O6-benzylguanine, an inhibitor of AGT, is used to sensitize tumors to chemotherapy.
DNA Repair Deficiency and Mutagenesis
Loss of protein-cysteine methyltransferase activity results in defective repair of O6-methylguanine, leading to mutations and cell death. Repair-deficient human lymphoid cells are hypersensitive to alkylating agents. This deficiency is associated with increased cancer risk and may contribute to hereditary cancer syndromes.
Neurodegeneration and Oxidative Stress
Redox-dependent cysteine methylation may protect against oxidative stress by modifying redox-sensitive proteins. In plants, nitric oxide-mediated chromatin remodeling involves cysteine methylation. In humans, dysregulation of redox signaling is linked to neurodegeneration, although direct evidence for protein-cysteine methyltransferase activity in neurodegeneration is limited.
Plant Stress Responses
In poplar leaves, ozone stress induces S-nitroso-proteome changes, suggesting a role for cysteine methylation in redox regulation and stress adaptation. This highlights the broader biological significance of the activity beyond human health.
From protein-cysteine methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MGMT Cys145 mutation abolish methyltransferase activity? | Point mutation (C145A) knock-in in cancer cell lines |
| What is the effect of MGMT knockout on temozolomide sensitivity? | CRISPR knockout in glioblastoma cells |
| Can MGMT overexpression confer chemoresistance? | Overexpression via lentiviral transduction |
| How does S204 phosphorylation affect MGMT stability? | Phospho-mimetic (S204D) and phospho-deficient (S204A) knock-in |
| What are the off-targets of cysteine methylation? | Proteomics with methyl-specific antibodies in knockout backgrounds |
| Is AGT activity conserved in Drosophila? | Drosophila knockout and rescue with human MGMT |
How to Study the protein-cysteine methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive methyl transfer assay | Enzymatic activity using [3H]-SAM | Quantify MGMT activity in cell lysates |
| Mass spectrometry | S-methyl-cysteine modifications on proteins | Identify target proteins and sites |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complex | Understand catalytic mechanism |
| CRISPR knockout screens | Gene essentiality and drug sensitivity | Identify modifiers of alkylating agent response |
| Western blot | Protein expression and degradation | Assess MGMT stability and phosphorylation |
| Immunofluorescence | Subcellular localization | Determine nuclear localization of MGMT |
| S-nitroso-proteome analysis | Redox-sensitive cysteine modifications | Study crosstalk with nitric oxide signaling |
| Drosophila survival assays | Organismal sensitivity to alkylating agents | Genetic studies of repair |
Biochemical Assays for Methyltransferase Activity
Methyltransferase activity can be measured using radioactive SAM ([3H]-SAM) and detecting methyl transfer to protein substrates. For MGMT, a standard assay uses [3H]-methylated DNA as substrate and measures radioactivity transferred to the protein. Alternatively, mass spectrometry can detect S-methyl-L-cysteinyl modifications.
Structural Biology and Crystallography
X-ray crystallography and NMR can reveal the active site geometry and conformational changes during catalysis. Structures of human MGMT have shown the cysteine nucleophile and DNA-binding domain.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to alkylating agents, including MGMT and related repair factors. These screens link genotype to phenotype and uncover synthetic lethal interactions.
Proteomics and Redox Proteomics
Mass spectrometry-based proteomics can identify proteins with S-methyl-cysteine modifications. Redox proteomics, such as S-nitroso-proteome analysis, can reveal crosstalk between cysteine methylation and redox signaling.
How CRISPR Can Be Used to Study GO:0106363 protein-cysteine methyltransferase activity
Knockout
CRISPR knockout of MGMT or AGT genes can abolish protein-cysteine methyltransferase activity, leading to hypersensitivity to alkylating agents. This is useful for validating the role of the enzyme in DNA repair and for creating isogenic models to study chemoresistance.
Point Mutation
Point mutations at the catalytic cysteine (e.g., C145A in MGMT) can be introduced to dissect the enzymatic mechanism and separate methyltransferase activity from other functions. Such mutants serve as negative controls in activity assays.
Knock-in
Knock-in of tagged or phospho-mimetic variants (e.g., S204D) allows real-time tracking of protein stability and localization. This helps understand how post-translational modifications regulate methyltransferase activity.
Overexpression
Overexpression of MGMT via CRISPR activation or lentiviral delivery can model chemoresistance and study the consequences of elevated repair activity on genome stability and therapy response.
How EDITGENE Supports protein-cysteine methyltransferase activity Research
Researchers studying protein-cysteine methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in DNA repair, chemoresistance, or redox regulation. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling precise functional dissection of this activity.
Contact EDITGENE today to design your custom CRISPR model for protein-cysteine methyltransferase activity research.
Frequently Asked Questions About protein-cysteine methyltransferase activity
What is protein-cysteine methyltransferase activity?
It is an enzyme activity (GO:0106363) that transfers a methyl group from S-adenosyl-L-methionine to a cysteine residue on a protein, forming S-methyl-L-cysteinyl-[protein] and S-adenosyl-L-homocysteine.
What genes are involved in protein-cysteine methyltransferase activity?
Key genes include MGMT in humans, AGT in E. coli, and homologs in Drosophila. Other potential targets include redox-sensitive proteins.
What is the role of MGMT in DNA repair?
MGMT removes alkyl groups from O6-alkylguanine in DNA by transferring them to its own cysteine residue, restoring DNA integrity.
How is protein-cysteine methyltransferase activity measured?
It can be measured using radioactive methyl transfer assays with [3H]-SAM or [3H]-methylated DNA, and by mass spectrometry.
What diseases are associated with protein-cysteine methyltransferase activity?
Deficiency is linked to cancer predisposition and hypersensitivity to alkylating agents; high activity causes chemoresistance in glioblastoma and other cancers.
What is the reaction catalyzed by protein-cysteine methyltransferase?
L-cysteinyl-[protein] + S-adenosyl-L-methionine = H+ + S-adenosyl-L-homocysteine + S-methyl-L-cysteinyl-[protein].
Is protein-cysteine methyltransferase activity a suicide enzyme?
Yes, the methylated enzyme is inactivated and often degraded, so each molecule repairs only one lesion.
How does phosphorylation regulate MGMT?
Phosphorylation at serine-204 increases resistance to proteolytic digestion, stabilizing the protein.
Can CRISPR be used to study protein-cysteine methyltransferase activity?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect gene function and enzymatic activity.
What are the synonyms for GO:0106363?
Protein cysteine methylase activity and protein cysteine methyltransferase activity.
Conclusion
Protein-cysteine methyltransferase activity (GO:0106363) is a fundamental enzymatic function with critical roles in DNA repair, genome stability, and cellular stress responses. Its best-characterized member, MGMT, directly reverses alkylation damage and influences cancer chemotherapy outcomes. Ongoing research into its regulation, substrate specificity, and broader biological functions promises new insights into disease mechanisms and therapeutic opportunities. EDITGENE's CRISPR services empower researchers to explore this activity with precision and scale.
References
- 1. Lim IK et al.. 2000. Phosphorylation of methylated-DNA-protein-cysteine S-methyltransferase at serine-204 significantly increases its resistance to proteolytic digestion.. Biochem J 352 Pt 3(Pt 3):801-8 PMID: 11104689
- 2. Shiotani A et al.. 2013. Eradication of gastric cancer is now both possible and practical.. Semin Cancer Biol 23(6 Pt B):492-501 PMID: 23876852
- 3. Ageeva-Kieferle A et al.. 2019. Redox-Dependent Chromatin Remodeling: A New Function of Nitric Oxide as Architect of Chromatin Structure in Plants.. Front Plant Sci 10:625 PMID: 31191565
- 4. Guzder SN et al.. 1991. Drosophila methyltransferase activity and the repair of alkylated DNA.. Mutat Res 255(2):143-53 PMID: 1717843
- 5. Vanzo E et al.. 2014. S-nitroso-proteome in poplar leaves in response to acute ozone stress.. PLoS One 9(9):e106886 PMID: 25192423
- 6. Olsson M et al.. 1980. Repair of alkylated DNA in Escherichia coli. Methyl group transfer from O6-methylguanine to a protein cysteine residue.. J Biol Chem 255(22):10569-71 PMID: 7000780
- 7. Elder RH et al.. 1994. Differential inactivation of mammalian and Escherichia coli O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine.. Biochem J 298 ( Pt 1)(Pt 1):231-5 PMID: 8129725
- 8. Harris AL et al.. 1983. O6-Methylguanine-DNA methyltransferase of human lymphoid cells: structural and kinetic properties and absence in repair-deficient cells.. Cancer Res 43(7):3247-52 PMID: 6342762
